The design of cobalt(III) complexes of phenazine-1-carboxamides as prointercalators and potential hypoxia-selective cytotoxins

Citation
Lc. Perrin et al., The design of cobalt(III) complexes of phenazine-1-carboxamides as prointercalators and potential hypoxia-selective cytotoxins, ANTI-CAN DR, 14(3), 1999, pp. 231-241
Citations number
24
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTI-CANCER DRUG DESIGN
ISSN journal
02669536 → ACNP
Volume
14
Issue
3
Year of publication
1999
Pages
231 - 241
Database
ISI
SICI code
0266-9536(199906)14:3<231:TDOCCO>2.0.ZU;2-5
Abstract
A series of cobalt (III) complexes, [Co(Racac)(2)(L)](+), have been prepare d as potential hypoxia-selective prointercalator forms of the ligands L, wh ere L is the cytotoxic DNA monointercalating ligands N-[2-[(aminoethyl)amin o]ethyl]-phenazine-1-carboxamide and N-[5-[(aminoethyl)amino]pentyl]-phenaz ine-1-carboxamide or the potentially bis(intercalating) ligand bis[2-(phena zine-1- carboxamido)ethyl]-1,2-diaminoethane. The cobalt(III) complexes of the monointercalating ligands have significantly lower DNA binding affinity and cytotoxicity than the ligands themselves, indicating the potential uti lity of this prodrug approach for deactivation land release under hypoxic c onditions). However, the complexes showed only low hypoxic selectivity. The complex of the bis(intercalating) ligand also showed significantly lower D NA binding affinity than the free ligand, but in this case there was no att enuation of cytotoxicity.